Bladder Cancer Studies

Selected Posters and Publications

2016

Programmed death-ligand 1 (PD-L1) Characterization of Circulating Tumor Cells (CTCs) in Muscle Invasive and Metastatic Bladder Cancer Patients. ASCO GU 2016

Anantharaman, A et al. Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients. BMC Cancer 201616:744 DOI: 10.1186/s12885-016-2758-3

2015

Programmed death-ligand 1 (PD-L1) Characterization of Circulating Tumor Cells (CTCs) and White Blood Cells (WBCs) in Muscle Invasive and Metastatic Bladder Cancer Patients. ASCO GU 2015

Return to Posters

Return to Technical Resources

Return to Analysis by Cancer Indication